Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Neal

Showing results (101-110 of 122) with videos related to

Pageof 13
Sort By:
Digital Health|August 5, 2025
Digital assistive technologies for community-dwelling people with dementia: A systematic review of systematic reviews by the INTERDEM AI & assistive technology taskforceDavid Neal, Michael P Craven, Jane Cross, et al.
World Journal of Urology|January 3, 2012
Evaluating the PCPT risk calculator in ten international biopsy cohorts: results from the Prostate Biopsy Collaborative GroupDonna P Ankerst, Andreas Boeck, Stephen J Freedland, et al.
World Journal of Urology|April 25, 2012
Evaluating the Prostate Cancer Prevention Trial High Grade Prostate Cancer Risk Calculator in 10 international biopsy cohorts: results from the Prostate Biopsy Collaborative GroupDonna P Ankerst, Andreas Boeck, Stephen J Freedland, et al.
International Journal of Epidemiology|January 1, 2019
Circulating vitamin D concentrations and risk of breast and prostate cancer: a Mendelian randomization studyXia Jiang, Niki L Dimou, Kawthar Al-Dabhani, et al.
Behavioral Sciences (Basel, Switzerland)|April 26, 2025
Effective for Whom? A Review of Psychological and Social Intervention Recommendations in European Dementia Care Guidelines Through the Lenses of Social Health and IntersectionalityDavid Neal, Sara Laureen Bartels, Saloua Berdai Chaouni, et al.
Nature Communications|August 31, 2017
Synthetic lethality between androgen receptor signalling and the PARP pathway in prostate cancerMohammad Asim, Firas Tarish, Heather I Zecchini, et al.
Nature Communications|April 2, 2015
Tracking the origins and drivers of subclonal metastatic expansion in prostate cancerMatthew K H Hong, Geoff Macintyre, David C Wedge, et al.
Cancer Research|November 29, 2013
Prognostic and therapeutic impact of argininosuccinate synthetase 1 control in bladder cancer as monitored longitudinally by PET imagingMichael D Allen, Phuong Luong, Chantelle Hudson, et al.
Health Technology Assessment (Winchester, England)|August 11, 2020
Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: the ProtecT three-arm RCTFreddie C Hamdy, Jenny L Donovan, J Athene Lane, et al.
International Journal of Cancer|October 15, 2016
Investigating the possible causal role of coffee consumption with prostate cancer risk and progression using Mendelian randomization analysisAmy E Taylor, Richard M Martin, Milan S Geybels, et al.
Pageof 13

Showing results (101-110 of 122) with videos related to

Sort By:
Pageof 13
Digital Health|August 5, 2025
Digital assistive technologies for community-dwelling people with dementia: A systematic review of systematic reviews by the INTERDEM AI & assistive technology taskforceDavid Neal, Michael P Craven, Jane Cross, et al.
World Journal of Urology|January 3, 2012
Evaluating the PCPT risk calculator in ten international biopsy cohorts: results from the Prostate Biopsy Collaborative GroupDonna P Ankerst, Andreas Boeck, Stephen J Freedland, et al.
World Journal of Urology|April 25, 2012
Evaluating the Prostate Cancer Prevention Trial High Grade Prostate Cancer Risk Calculator in 10 international biopsy cohorts: results from the Prostate Biopsy Collaborative GroupDonna P Ankerst, Andreas Boeck, Stephen J Freedland, et al.
International Journal of Epidemiology|January 1, 2019
Circulating vitamin D concentrations and risk of breast and prostate cancer: a Mendelian randomization studyXia Jiang, Niki L Dimou, Kawthar Al-Dabhani, et al.
Behavioral Sciences (Basel, Switzerland)|April 26, 2025
Effective for Whom? A Review of Psychological and Social Intervention Recommendations in European Dementia Care Guidelines Through the Lenses of Social Health and IntersectionalityDavid Neal, Sara Laureen Bartels, Saloua Berdai Chaouni, et al.
Nature Communications|August 31, 2017
Synthetic lethality between androgen receptor signalling and the PARP pathway in prostate cancerMohammad Asim, Firas Tarish, Heather I Zecchini, et al.
Nature Communications|April 2, 2015
Tracking the origins and drivers of subclonal metastatic expansion in prostate cancerMatthew K H Hong, Geoff Macintyre, David C Wedge, et al.
Cancer Research|November 29, 2013
Prognostic and therapeutic impact of argininosuccinate synthetase 1 control in bladder cancer as monitored longitudinally by PET imagingMichael D Allen, Phuong Luong, Chantelle Hudson, et al.
Health Technology Assessment (Winchester, England)|August 11, 2020
Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: the ProtecT three-arm RCTFreddie C Hamdy, Jenny L Donovan, J Athene Lane, et al.
International Journal of Cancer|October 15, 2016
Investigating the possible causal role of coffee consumption with prostate cancer risk and progression using Mendelian randomization analysisAmy E Taylor, Richard M Martin, Milan S Geybels, et al.
Pageof 13